Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 4Phase 3 3Phase NA 1Phase 1 1

Status

Unknown 4Completed 4Recruiting 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Lymphoid 1Gastrointestinal 1

Conditions

Recurrence 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 28Cisplatin 28Carboplatin 27Capecitabine 27camrelizumab 25Nivolumab 24apatinib 23Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 19Drug Therapy 18Immunotherapy, Adoptive 17pembrolizumab 16Docetaxel 16Bevacizumab 16Dexamethasone 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12Fluorouracil 11130-nm albumin-bound paclitaxel 11anlotinib 10Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Valproic Acid × Clear all
NCT01898104 2023-03-24

V-shoRT-R3

National Cancer Institute, Naples

Phase 1/2 Unknown
152 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01369368 2015-06-24

Treatment of Acute Leukemia Relapse After Allotransplantation

University of Bergen

Phase 1/2 Unknown
20 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT01295593 2012-06-07

Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 1/2 Unknown
33 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01203735 2011-03-29

Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer

Soroka University Medical Center

Phase 1/2 Unknown
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡